Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws.
BACKGROUND:Community mass treatment with 30 mg/kg azithromycin is central to the new WHO strategy for eradicating yaws. Both yaws and trachoma--which is earmarked for elimination by 2020 using a strategy that includes mass treatment with 20 mg/kg azithromycin--are endemic in the Pacific, raising the...
Saved in:
Main Authors: | Michael Marks (Author), Ventis Vahi (Author), Oliver Sokana (Author), Kai-Hua Chi (Author), Elliot Puiahi (Author), Georgina Kilua (Author), Allan Pillay (Author), Tenneth Dalipanda (Author), Christian Bottomley (Author), Anthony W Solomon (Author), David C Mabey (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
by: Michael Marks, et al.
Published: (2016) -
Evaluation of a rapid diagnostic test for yaws infection in a community surveillance setting.
by: Michael Marks, et al.
Published: (2014) -
Single-dose azithromycin to treat latent yaws
by: Michael Marks, et al.
Published: (2017) -
A cross-sectional study of 'yaws' in districts of Ghana which have previously undertaken azithromycin mass drug administration for trachoma control.
by: Rosanna Ghinai, et al.
Published: (2015) -
Failure of PCR to Detect Treponema pallidum ssp. pertenue DNA in Blood in Latent Yaws.
by: Michael Marks, et al.
Published: (2015)